| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Fennec Pharmaceuticals Inc (NASDAQ: FENC)
FENC Technical Analysis
5
| As on 9th Jun 2023 FENC STOCK Price closed @ 8.63 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 6.24 & Strong Buy for SHORT-TERM with Stoploss of 4.75 we also expect STOCK to react on Following IMPORTANT LEVELS. |
FENCSTOCK Price
| Open | 8.70 | Change | Price | % |
| High | 8.84 | 1 Day | 0.01 | 0.12 |
| Low | 8.47 | 1 Week | 1.05 | 13.85 |
| Close | 8.63 | 1 Month | 0.09 | 1.05 |
| Volume | 81547 | 1 Year | 4.42 | 104.99 |
| 52 Week High 10.35 | 52 Week Low 4.18 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| FENC Daily Charts |
FENC Intraday Charts |
Whats New @ Bazaartrend |
FENC Free Analysis |
|
|
FENC Important Levels Intraday
| RESISTANCE | 9.34 |
| RESISTANCE | 9.11 |
| RESISTANCE | 8.97 |
| RESISTANCE | 8.83 |
| SUPPORT | 8.43 |
| SUPPORT | 8.29 |
| SUPPORT | 8.15 |
| SUPPORT | 7.92 |
FENC Forecast April 2024
| 4th UP Forecast | 11.31 |
| 3rd UP Forecast | 10.45 |
| 2nd UP Forecast | 9.92 |
| 1st UP Forecast | 9.39 |
| 1st DOWN Forecast | 7.87 |
| 2nd DOWN Forecast | 7.34 |
| 3rd DOWN Forecast | 6.81 |
| 4th DOWN Forecast | 5.95 |
FENC Weekly Forecast
| 4th UP Forecast | 9.52 |
| 3rd UP Forecast | 9.23 |
| 2nd UP Forecast | 9.06 |
| 1st UP Forecast | 8.88 |
| 1st DOWN Forecast | 8.38 |
| 2nd DOWN Forecast | 8.20 |
| 3rd DOWN Forecast | 8.03 |
| 4th DOWN Forecast | 7.74 |
FENC Forecast2024
| 4th UP Forecast | 21.64 |
| 3rd UP Forecast | 17.47 |
| 2nd UP Forecast | 14.89 |
| 1st UP Forecast | 12.31 |
| 1st DOWN Forecast | 4.95 |
| 2nd DOWN Forecast | 2.37 |
| 3rd DOWN Forecast | -0.21 |
| 4th DOWN Forecast | -4.38 |
Fennec Pharmaceuticals Inc ( NASDAQ USA Symbol : FENC )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
FENC Business Profile
Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product PEDMARK, a formulation of Sodium Thiosulfate, which has completed the Phase III clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina. Address: 68 TW Alexander Drive, Research Triangle Park, NC, United States, 27709
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service